Document is current
Any future updates will be listed below
-
Authors
Ju, Cheng-Wei https://orcid.org/0000-0002-2250-8548
Li, Han https://orcid.org/0000-0002-4350-6314
Jiang, Bochen https://orcid.org/0000-0001-6686-8847
Zhu, Xuanhao
Cui, Liang https://orcid.org/0000-0001-9356-825X
Han, Zhanghui
Zou, Junxi
Liu, Yunzheng
Shen, Shenghai
Shah, Hardik https://orcid.org/0000-0001-8408-5686
Ye, Chang https://orcid.org/0000-0003-0236-5671
Zhong, Yuhao
Ge, Ruiqi https://orcid.org/0000-0002-8529-3070
Xia, Peng https://orcid.org/0000-0002-6046-3790
Ji, Yiyi https://orcid.org/0000-0001-5598-0059
Liu, Shun https://orcid.org/0000-0001-8850-9079
Yang, Fan
Liu, Bei
Xu, Yuzhi
Wei, Jiangbo https://orcid.org/0000-0003-2691-6490
Zhang, Li-Sheng https://orcid.org/0000-0003-1872-9978
He, Chuan https://orcid.org/0000-0003-4319-7424
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 1 September 2025
First Online: 6 October 2025
Competing interests
: C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio, Inc., AllyRNA, Inc., and Ellis Bio, Inc., a scientific cofounder and equity holder of Accent Therapeutics, Inc., and a member of the scientific advisory board of Rona Therapeutics. The remaining authors declare no competing interests.
